<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28125976</article-id>
<article-id pub-id-type="pmc">5270287</article-id>
<article-id pub-id-type="publisher-id">368</article-id>
<article-id pub-id-type="doi">10.1186/s12881-017-0368-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of novel candidate variants including <italic>COL6A6</italic> polymorphisms in early-onset atopic dermatitis using whole-exome sequencing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Heo</surname>
<given-names>Won Il</given-names>
</name>
<address>
<email>onebbang1234@naver.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Kui Young</given-names>
</name>
<address>
<email>momo920@hanmail.net</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Taewon</given-names>
</name>
<address>
<email>j.magma@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Mi-Kyung</given-names>
</name>
<address>
<email>cpworld@cau.ac.kr</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>MinJeong</given-names>
</name>
<address>
<email>moyalmin@nate.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Eung Ho</given-names>
</name>
<address>
<email>choieh@yonsei.ac.kr</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hae-Suk</given-names>
</name>
<address>
<email>haesuk.kim@therabio.kr</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bae</surname>
<given-names>Jung Min</given-names>
</name>
<address>
<email>jminbae@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moon</surname>
<given-names>Nam Ju</given-names>
</name>
<address>
<email>njmoon@chol.com</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Seo</surname>
<given-names>Seong Jun</given-names>
</name>
<address>
<phone>82-2-6299-1538</phone>
<email>drseo@hanafos.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0647 4960</institution-id><institution-id institution-id-type="GRID">grid.411651.6</institution-id><institution>Department of Dermatology, </institution><institution>Chung-Ang University Hospital, </institution></institution-wrap>Heukseok-Ro 102, Dongjak-Gu, Seoul, South Korea </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0647 4960</institution-id><institution-id institution-id-type="GRID">grid.411651.6</institution-id><institution>Department of Laboratory Medicine, </institution><institution>Chung-Ang University Hospital, </institution></institution-wrap>Seoul, South Korea </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution>Department of Dermatology, </institution><institution>Yonsei University Wonju College of Medicine, </institution></institution-wrap>Wonju, South Korea </aff>
<aff id="Aff4"><label>4</label>TheragenEtex Bio Institute Inc., Suwon, South Korea </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 4224</institution-id><institution-id institution-id-type="GRID">grid.411947.e</institution-id><institution>Department of Dermatology, St. Vincent’s Hospital, College of Medicine, </institution><institution>Catholic University of Korea, </institution></institution-wrap>Suwon, South Korea </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0647 4960</institution-id><institution-id institution-id-type="GRID">grid.411651.6</institution-id><institution>Department of Ophthalmology, </institution><institution>Chung-Ang University Hospital, </institution></institution-wrap>Seoul, South Korea </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>18</volume>
<elocation-id>8</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>The prevalence of atopic dermatitis has increased over the last 10 years. Atopic dermatitis tends to run in families and commonly begins to manifest in childhood. The prevalence of atopic dermatitis is as high as 20% in children. Thus, early diagnosis and treatment of atopic dermatitis are important. Understanding its genetic basis is also needed to facilitate early detection.</p>
</sec>
<sec>
<title>Methods</title>
<p>To identify family-specific candidate genetic variants associated with early-onset atopic dermatitis in Koreans, we carried out whole-exome sequencing of three separate families with this condition. Additional validation was performed in 112 AD patients and 61 controls using Sanger sequencing.</p>
</sec>
<sec>
<title>Results</title>
<p>We focused on both common functional variants with a minor allele frequency higher than 1% and rare variants with a minor allele frequency less than 1%. The relevance of the respective variants was supported by a program that could predict whether the mutations resulted in damaged protein function. Fourteen overlapping genes were identified during exome sequencing. Three variants of the <italic>COL6A6</italic> gene appeared in all three families and were in close proximity to atopic dermatitis-related loci on chromosome 3q21. The homozygous frequency for the rs16830494 minor allele (AA) and the rs59021909 (TT) allele and the rs200963433 heterozygous (CT) frequency were all higher in AD cases compared to controls in a population-based case-control study.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Identifying family-specific <italic>COL6A6</italic> polymorphisms and genetic variants of other candidate genes associated with AD using WES is a novel approach. Our study suggests that <italic>COL6A6</italic> variants may be risk factors for atopic dermatitis. This study provides a genetic basis for early-onset AD diagnosis in Korean patients and the development of new therapies.</p>
</sec>
<sec>
<title>Trial registration</title>
<p>Trial registration number: IRB NO. C2008030 (133); Name of registry: The collection research of clinical data and patient blood to identify genetic and protein biomarker of atopic dermatitis; Date of registration: 09-July-2008.</p>
<p>Trial registration number: IRB NO. C2015258 (1716); Name of registry: The collection study of patient blood and clinical data for the development of the prognosis prediction and early diagnosis of atopic dermatitis; Date of registration: 15-jan-2016.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s12881-017-0368-9) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>
<italic>COL6A6</italic>
</kwd>
<kwd>Atopic dermatitis</kwd>
<kwd>Sanger sequencing</kwd>
<kwd>Whole-exome sequencing</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003625</institution-id>
<institution>Ministry of Health and Welfare</institution>
</institution-wrap>
</funding-source>
<award-id>HI14C2687</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin disorder characterized by eczematous lesions and dry, itchy skin. AD seems to be caused by a combination of hereditary and environmental factors. Although AD has features of a multigenic syndrome, it tends to run in families and commonly begins to manifest in childhood [<xref ref-type="bibr" rid="CR1">1</xref>]. In a large cohort study of family history, AD was determined to be inherited in an autosomal dominant fashion [<xref ref-type="bibr" rid="CR2">2</xref>]. There are strong genetic heritable components in many other common and complex diseases [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p>AD occurs at a rate as high as 20% in children [<xref ref-type="bibr" rid="CR4">4</xref>]. Understanding the genetic background, early discovery, and best therapies for AD is important. Thus, identification of causal variants associated with a common complex trait like AD is needed for early detection.</p>
<p>Whole-exome sequencing (WES) is a technique that involves the sequencing of all protein-coding genes, known as the exome, which is comprised of about 3×10<sup>7</sup> bases. Although the exome constitutes less than 2% of the human genome, mutations in the exome can have more severe consequences than do mutations in the other 98% of the human genome [<xref ref-type="bibr" rid="CR5">5</xref>]. The purpose of WES is to identify variations by filtering big data collected from all protein-coding regions. This data includes disease-causing mutations inherited in a Mendelian pattern or disease-predisposing single-nucleotide polymorphisms (SNPs) found in both common and complex disorders [<xref ref-type="bibr" rid="CR6">6</xref>]. To identify familial causative variants of early-onset AD, we recruited three pedigrees from families with a history of AD and severe clinical phenotypes. We then performed WES on all involved individuals. Alleles were compared to identify causal variants and subsequently validated in a population-based case-control study using Sanger sequencing.</p>
<p>A considerable number of rare and common variants were found, and 14 overlapping genes were detected in the three families. The common disease-common variant (CD-CV) hypothesis can best be tested in genome-wide association studies (GWASs). However, the hypothesis that individually gathered rare variants have severe effects arose from issues of missing heritability in the CD-CV hypothesis [<xref ref-type="bibr" rid="CR7">7</xref>]. Common variants of common diseases were recently reported to be shared among different races [<xref ref-type="bibr" rid="CR8">8</xref>]. The importance of common and rare variants is still uncertain [<xref ref-type="bibr" rid="CR9">9</xref>]. Thus, we aimed to identify not only rare variants, but also common variants.</p>
<p>Linkage analysis is used to determine the rough positions of causal genes relative to known genetic makers. An AD linkage analysis found that chromosome region 1q21 contains an epidermal differentiation complex (EDC). The EDC includes various AD-related genes (e.g., loricrin, involucrin, filaggrin, and the S100 family) [<xref ref-type="bibr" rid="CR10">10</xref>]. We used AD-related loci to confirm the association of the 14 overlapping genes with AD [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p>Here, we report the WES results from familes with early-onset AD, and we suggest the possibility of new variants, <italic>COL6A6</italic> polymorphisms, as novel candidate for the detection of early-onset AD.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Patients</title>
<p>Peripheral blood samples were obtained from three families with a history of AD. Each family consists of 2 affected and 2 unaffected individuals (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). We attempted to eliminate environmental factors as much as possible by recruiting early-onset cases. This study was reviewed and approved by the Chung-Ang University Hospital Institutional Review Board. Each family member was diagnosed with AD by a dermatologist. All patients and children developed AD before 2 years of age and were selected based on high IgE level (&gt;1000) and SCORAD score (&gt;50). Additionally, 112 AD patients and 61 control subjects under 2 years 9 months old were enrolled to validate the association between the candidate variants and atopic dermatitis (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1).</p>
</sec>
<sec id="Sec4">
<title>Whole-exome sequencing</title>
<p>Genomic DNA was isolated from the peripheral blood of the members of the three families using a QIAamp DNA Mini Kit (Qiagen Inc, Valencia, CA, USA). The DNA quality and quantity were assessed with a Nanodrop spectrometer (Nanodrop Technologies, Wilmington, DE, USA) and a Qubit fluorometer (Life Technologies, Grand Island, NY, USA). WES was performed using SureSelect Human All Exon V4 + UTR 71 Mb (Agilent, CA, USA), following the manufacturer’s standard protocol. Genomic DNA was sheared using Covaris (Covaris, Woburn, MA, USA). A paired-end DNA sequencing library was prepared through shearing, end-repair, A-tailing, peak detection, PE adaptor ligation, and amplification. After the library was hybridized with bait sequences for 24 h, it was purified and amplified with an index barcode tag, and the library quality and quantity were determined. The exome library was sequenced with the 100-bp paired-end mode of the HiSeq SBS kit.</p>
</sec>
<sec id="Sec5">
<title>Whole-exome sequencing processing and alignment</title>
<p>Sequence reads in FASTQ format were mapped to the human assembly UCSC hg19 using the Burrows-Wheeler Aligner (BWA, v0.7.7) [<xref ref-type="bibr" rid="CR12">12</xref>] with “mem” and seed value parameters “-k 45” to create SAM files with correct mate pair information. The read group tag included the sample name. Picard (v1.92) was then used to convert the SAM files to compressed BAM files and then to sort the BAM files by chromosome coordinate. The Genome Analysis Toolkit (v2.3.9Lite) [<xref ref-type="bibr" rid="CR13">13</xref>] was used to locally realign the BAM files at intervals corresponding to potential insertion/deletion (indel) alignment errors. Insertions and deletions were identified with Mutect [<xref ref-type="bibr" rid="CR14">14</xref>] and a GATK Somatic Indel Detector, respectively. Single-nucleotide variants and indels were annotated using snpEff (v3.6c) [<xref ref-type="bibr" rid="CR15">15</xref>] to classify variants as synonymous, non-synonymous, missense, frameshift point mutations, or frameshift indels.</p>
</sec>
<sec id="Sec6">
<title>Annotation</title>
<p>Filter 1: SnpEff (<ext-link ext-link-type="uri" xlink:href="http://snpeff.sourceforge.net/index.html">http://snpeff.sourceforge.net/index.html</ext-link>) is a type of variant annotation and an effect prediction tool. It annotates and predicts the effects of variants, such as amino acid changes, on genes. Variants produce effects of different “types” (e.g., non-synonymous, stop-gained, insertion, deletion).</p>
<p>Filter 2: Impact prediction by SnpEff shows results of putative variants, making it easier to quickly categorize and prioritize variants (High: Splice_Site_Acceptor, Splice_Site_Donor, Start_Lost, Frame_Shift, Stop_Gained; Moderate: Non_Synonymous_coding, Codon_Change, Codon_Insertion and Deletion, etc.).</p>
<p>Filter 3: SIFT and Polyphen2 of dbNSFP</p>
<p>The SIFT score predicts whether an amino acid substitution affects protein function. SIFT prediction is based on the degree of amino acid conservation in aligned segments derived from closely related sequences, as collected through PSI-BLAST. The range was 0 to 1; substitutions with scores lower than 0.05 were predicted to be damaging (a lower score signified a greater detrimental effect), whereas substitutions with higher scores were predicted to be tolerable.</p>
<p>The Polyphen2 HDIV score was based on HumDiv, i.e., hdiv_prob. The score ranged from 0 to 1, and a higher score suggested a greater degree of predicted damage. A prediction of “probably damaging” corresponded to scores between 0.957 and 1, “possibly damaging” for scores ranging from 0.453 to 0.956, and “benign” for those between 0 and 0.452.</p>
<p>Filter 4: The PhyloP of dbNSFP detects sites under negative or positive selection while allowing for changes in evolution rate over the branches of the phylogenetic tree. A higher PhyloP score indicates a better conserved site (<ext-link ext-link-type="uri" xlink:href="http://varianttools.sourceforge.net/Annotation/DbNSFP">http://varianttools.sourceforge.net/Annotation/DbNSFP</ext-link>).</p>
<p>Filter 5: PhastCons measures the strength of purifying selection acting on a DNA sequence. A high PhastCons score (0.2) is strong evidence that a genomic region is functionally important.</p>
<p>Filter 6: The 1000 Genome allele frequency of dbNSFP selects variants with frequencies of less than 0.01 or those with unknown frequencies.</p>
<p>Filter 7: The in-house Korean database at the Theragen Etex Bio Institute selects variants with minor allele frequencies (MAFs, less than 0.02 or unknown).</p>
</sec>
<sec id="Sec7">
<title>Sanger sequencing</title>
<p>Three SNPs were selected for Sanger validation. PCR amplification of all SNPs was performed at 95 °C for 10 min, followed by 35 cycles at 95 °C for 30 s, 55–58 °C for 30 s and 72 °C for 40 s, with a final extension at 72 °C for 1 min 30 s. The PCR mixtures (total volume 50 μL) contained 25 μL of 2X EF-Taq premix (SolGent, Seoul, South Korea), 2.5 μL of oligonucleotide primer (10 pmol/μL), 18 μL of distilled water, and 2 μL of template containing 20 ng genomic DNA. The PCR products underwent purification via a PCR purification kit (Favorgen, Pingtung, Taiwan) and were sequenced on an Applied Biosystems 3500 DNA sequencer (Foster City, CA, USA) according to the manufacturer’s instructions.</p>
</sec>
</sec>
<sec id="Sec8">
<title>Results</title>
<sec id="Sec9">
<title>Whole-exome sequencing in three families with atopic dermatitis</title>
<p>WES was performed on three families with AD. To limit our study to genetic factors, we recruited three pedigrees from families with severe clinical AD phenotypes and attempted to minimize environmental factors by selecting early-onset cases. The WES analysis showed that all affected individuals were heterozygous for the identified variants, while unaffected individuals were homozygous wild-type (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Genotypes of overlapping common and rare variants in three families</p></caption><graphic id="MO1" xlink:href="12881_2017_368_Tab1_HTML"></graphic></table-wrap>
</p>
<p>A large amount of WES data from each individual exome were filtered in a stepwise fashion to isolate candidate variants related to AD (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2). The variants collected from the three families were counted after each filtering process. We obtained an average of 176 common variants per family after filter 4 and an average of 48 rare variants following the 1000 Genome filter 5. An average of 44 rare variants were detected after the Korean filter (Table <xref ref-type="table" rid="Tab2">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Number of variants by filter in three families using a dominant genetic model</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Filter system</th><th colspan="3">Dominant model</th></tr><tr><th>Filter step</th><th>Filter process</th><th>Family A</th><th>Family B</th><th>Family C</th></tr></thead><tbody><tr><td>Raw</td><td>–</td><td>7523</td><td>3564</td><td>3227</td></tr><tr><td>Filter 1</td><td>EFFECT</td><td>2799</td><td>2489</td><td>2198</td></tr><tr><td>Filter 2</td><td>IMPACT</td><td>502</td><td>516</td><td>443</td></tr><tr><td>Filter 3</td><td>SIFT, PolyPhen2</td><td>278</td><td>258</td><td>231</td></tr><tr><td>Filter 4</td><td>phyloP</td><td>234</td><td>225</td><td>206</td></tr><tr><td>Filter 5</td><td>Phastcon</td><td>200</td><td>173</td><td>156</td></tr><tr><td>Filter 6</td><td>1000 genome</td><td>33</td><td>60</td><td>53</td></tr><tr><td>Filter 7</td><td>Korean</td><td>31</td><td>54</td><td>49</td></tr></tbody></table></table-wrap>
</p>
<p>Amino acid changes and variant types (non-synonymous SNP, stop-gained, insertion, deletion) were determined using the variant annotation from the step 1 filter. A non-synonymous SNP is a single-nucleotide change that results in a codon for a different amino acid. Considerable numbers of non-synonymous SNPs were observed in the three families (data not shown).</p>
<p>The variants identified by filter 5 not only indicated common variants (MAF greater than 1%), but also possible functional variants predicted to impair protein function as well as sequences that are highly conserved among 100 vertebrate species.</p>
<p>To find more critical variants among the many filtered genes, we confirmed the overlapping genes of common variants from filter 5 in the three families (Table <xref ref-type="table" rid="Tab1">1</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3). There were 14 overlapping genes in filter 5, four of which reached filter 7 and could be called “rare variants.” Risk alleles were identified in AD patients by comparison with healthy controls (Table <xref ref-type="table" rid="Tab1">1</xref>). The number of overlapping genes is also depicted as a Venn diagram (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3). Variants of <italic>COL6A6</italic> appeared in all three families (Tables <xref ref-type="table" rid="Tab3">3</xref>, <xref ref-type="table" rid="Tab4">4</xref> and <xref ref-type="table" rid="Tab5">5</xref>), and two <italic>COL6A6</italic> SNPs were detected in Family A (Table <xref ref-type="table" rid="Tab3">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Family-specific common and rare variants in Family A</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th colspan="6">Common variant</th><th colspan="6">Functional prediction program</th></tr><tr><th>Gene</th><th>RS#</th><th>
<sup>a</sup>Chr</th><th>
<sup>b</sup>POS</th><th>
<sup>c</sup>Amino acid change</th><th>Type</th><th>
<sup>d</sup>SIFT</th><th>
<sup>e</sup>Polyphen2</th><th>
<sup>f</sup>PhyloP</th><th>
<sup>g</sup>PhastCons</th><th>
<sup>h</sup>Global</th><th>East Asian</th><th>
<sup>i</sup>Korean</th></tr></thead><tbody><tr><td>
<italic>COL6A6</italic>
</td><td>16830494</td><td>chr3</td><td>130,361,856</td><td>R1739Q</td><td>cSNP</td><td>0.04</td><td>0.272</td><td>1.703</td><td>0.995</td><td>0.12</td><td>0.19</td><td>0.188</td></tr><tr><td>
<italic>ANKRD35</italic>
</td><td>11579366</td><td>chr1</td><td>145,562,293</td><td>E661Q</td><td>cSNP</td><td>0.38</td><td>0.971</td><td>5.285</td><td>1</td><td>0.39</td><td>0.26</td><td>0.233</td></tr><tr><td>
<italic>TUFT1</italic>
</td><td>3828054</td><td>chr1</td><td>151,512,895</td><td>Q18R</td><td>cSNP</td><td>0.77</td><td>0.688</td><td>1.688</td><td>0.288</td><td>0.1</td><td>0.03</td><td>0.047</td></tr><tr><td>
<italic>TMEM175</italic>
</td><td>34311866</td><td>chr4</td><td>951,947</td><td>M393T</td><td>cSNP</td><td>0.01</td><td>0</td><td>1.299</td><td>0.999</td><td>0.12</td><td>0.12</td><td>0.155</td></tr><tr><td>
<italic>EDN1</italic>
</td><td>5370</td><td>chr6</td><td>12,296,255</td><td>K198N</td><td>cSNP</td><td>0.08</td><td>0.454</td><td>0.049</td><td>0.001</td><td>0.21</td><td>0.28</td><td>0.258</td></tr><tr><td>
<italic>NRAP</italic>
</td><td>2270182</td><td>chr10</td><td>115,392,919</td><td>N519I</td><td>cSNP</td><td>0.19</td><td>0.958</td><td>2.477</td><td>1</td><td>0.26</td><td>0.20</td><td>0.205</td></tr><tr><td>
<italic>HGFAC</italic>
</td><td>16844401</td><td>chr4</td><td>3,449,652</td><td>R509H</td><td>cSNP</td><td>0.22</td><td>0.943</td><td>2.662</td><td>0.593</td><td>0.07</td><td>0.10</td><td>0.115</td></tr><tr><td>
<italic>UNC93A</italic>
</td><td>2235197</td><td>chr6</td><td>167,709,702</td><td>W151</td><td>STOP GAINED</td><td>.</td><td>.</td><td>4.525</td><td>1</td><td>0.1</td><td>0.15</td><td>0.163</td></tr><tr><td>
<italic>ABCA13</italic>
</td><td>1771229</td><td>chr7</td><td>48,313,881</td><td>F1540L</td><td>cSNP</td><td>.</td><td>0.997</td><td>2.325</td><td>0.614</td><td>0.11</td><td>0.17</td><td>0.255</td></tr><tr><td>
<italic>SSPO</italic>
</td><td>1005603</td><td>chr7</td><td>149,516,881</td><td>S4028I</td><td>cSNP</td><td>.</td><td>.</td><td>.</td><td>.</td><td>0.2</td><td>0.19</td><td>0.181</td></tr><tr><td>
<italic>TTC40</italic>
</td><td>12781609</td><td>chr10</td><td>134,748,331</td><td>S264N</td><td>cSNP</td><td>.</td><td>.</td><td>.</td><td>.</td><td>0.37</td><td>0.36</td><td>0.412</td></tr><tr><td>Rare variant</td><td colspan="12"></td></tr><tr><td>
<italic>DNAH17</italic>
</td><td>.</td><td>chr17</td><td>76,567,792</td><td>I204M</td><td>cSNP</td><td>0.11</td><td>.</td><td>1.926</td><td>0.992</td><td>.</td><td></td><td>.</td></tr><tr><td>
<italic>COL6A6</italic>
</td><td>200963433</td><td>chr3</td><td>130,289,976</td><td>R906C</td><td>cSNP</td><td>0</td><td>1</td><td>4.596</td><td>1</td><td>0.0014</td><td>0.01</td><td>0.017</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Chr = Chromosome</p><p>
<sup>b</sup>Pos = Position</p><p>
<sup>c</sup>Amino acid changes = single-letter codes for amino acids are presented, cSNP = single-nucleotide polymorphisms in coding regions</p><p>
<sup>d</sup>SIFT, prediction scores for amino acid substitutions that affect protein function (damaging &lt; 0.05, tolerance &gt; 0.05; scores range from 0 to 1)</p><p>
<sup>e</sup>Polyphen2, prediction of the possible impact of amino acid substitutions (0.957 &lt; probably damaging &lt; 1, 0.453 &lt; possibly damaging &lt; 0.956, 0 &lt; benign &lt; 0.452; scores range from 0 to 1)</p><p>
<sup>f</sup>PhyloP, prediction of conserved sites across species; a higher score indicates a more conserved site (values &gt; 0)</p><p>
<sup>g</sup>PhastCons, predicts the possibility that a nucleotide belongs to a conserved element in the phylogenetic tree (Values &gt; 0.2)</p><p>
<sup>h</sup>Global frequency, variants with MAFs as low as 1% or with an unknown frequency (value &lt; 0.01)</p><p>
<sup>i</sup>Korean frequency, variants with MAFs as low as 2% or in unknown genes (values &gt; 0.02)</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Family-specific common and rare variants in Family B</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th colspan="6">Common variant</th><th colspan="6">Functional prediction program</th></tr><tr><th>Gene</th><th>RS#</th><th>Chr</th><th>POS</th><th>Amino acid change</th><th>Type</th><th>SIFT</th><th>Polyphen2</th><th>PhyloP</th><th>PhastCons</th><th>Global</th><th>East Asian</th><th>Korean</th></tr></thead><tbody><tr><td>
<italic>COL6A6</italic>
</td><td>59021909</td><td>chr3</td><td>130,285,929</td><td>P556S</td><td>cSNP</td><td>0.11</td><td>0.999</td><td>2.136</td><td>0.997</td><td>0.09</td><td>0.08</td><td>0.119</td></tr><tr><td>
<italic>UVSSA</italic>
</td><td>2276904</td><td>chr4</td><td>1,349,029</td><td>R391H</td><td>cSNP</td><td>.</td><td>.</td><td>.</td><td>.</td><td>0.23</td><td>0.42</td><td>0.374</td></tr><tr><td>
<italic>TUFT1</italic>
</td><td>3828054</td><td>chr1</td><td>151,512,895</td><td>Q18R</td><td>cSNP</td><td>0.77</td><td>0.688</td><td>1.688</td><td>0.763</td><td>0.1</td><td>0.03</td><td>0.047</td></tr><tr><td>
<italic>TMEM175</italic>
</td><td>34311866</td><td>chr4</td><td>951,947</td><td>M393T</td><td>cSNP</td><td>0.01</td><td>0</td><td>1.299</td><td>0.563</td><td>0.12</td><td>0.12</td><td>0.155</td></tr><tr><td>
<italic>EDN1</italic>
</td><td>5370</td><td>chr6</td><td>12,296,255</td><td>K198N</td><td>cSNP</td><td>0.08</td><td>0.454</td><td>0.049</td><td>0.895</td><td>0.21</td><td>0.28</td><td>0.258</td></tr><tr><td>
<italic>NRAP</italic>
</td><td>868738</td><td>chr10</td><td>115,381,747</td><td>R884C</td><td>cSNP</td><td>0.01</td><td>0.986</td><td>4.833</td><td>1</td><td>0.24</td><td>0.17</td><td>0.198</td></tr><tr><td>Rare variant</td><td colspan="12"></td></tr><tr><td>
<italic>CDX1</italic>
</td><td>370852694</td><td>chr5</td><td>149,546,819</td><td>A127E</td><td>cSNP</td><td>0.87</td><td>0.458</td><td>1.235</td><td>0.996</td><td>.</td><td>.</td><td>0.027</td></tr><tr><td>
<italic>DNAH17</italic>
</td><td>78098467</td><td>chr17</td><td>76,510,974</td><td>A1332V</td><td>cSNP</td><td>0.6</td><td>.</td><td>4.052</td><td>1</td><td>0.01</td><td>0.04</td><td>0.037</td></tr><tr><td>
<italic>ANKRD35</italic>
</td><td>146839643</td><td>chr1</td><td>145,560,094</td><td>C194R</td><td>cSNP</td><td>0.01</td><td>1</td><td>3.419</td><td>1</td><td>0.0037</td><td>0.01</td><td>0.016</td></tr></tbody></table></table-wrap>
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Family-specific common and rare variants in Family C</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th colspan="6">Common variant</th><th colspan="6">Functional prediction program</th></tr><tr><th>Gene</th><th>#RS</th><th>Chr</th><th>POS</th><th>Amino acid change</th><th>Type</th><th>SIFT</th><th>Polyphen2</th><th>PhyloP</th><th>PhastCons</th><th>Global</th><th>East Asian</th><th>Korean</th></tr></thead><tbody><tr><td>
<italic>UVSSA</italic>
</td><td>2276904</td><td>chr4</td><td>1,349,029</td><td>R391H</td><td>cSNP</td><td>.</td><td>.</td><td>.</td><td>.</td><td>0.23</td><td>0.42</td><td>0.374</td></tr><tr><td>
<italic>HGFAC</italic>
</td><td>3748034</td><td>chr4</td><td>3,446,091</td><td>A218S</td><td>cSNP</td><td>0.38</td><td>0.659</td><td>2</td><td>1</td><td>0.15</td><td>0.28</td><td>0.305</td></tr><tr><td>
<italic>UNC93A</italic>
</td><td>2235197</td><td>chr6</td><td>167,709,702</td><td>W151</td><td>STOP GAINED</td><td>.</td><td>.</td><td>4.525</td><td>1</td><td>0.1</td><td>0.15</td><td>0.163</td></tr><tr><td>
<italic>ABCA13</italic>
</td><td>17712299</td><td>chr7</td><td>48,313,881</td><td>F1540L</td><td>cSNP</td><td>.</td><td>0.997</td><td>2.325</td><td>0.85</td><td>0.11</td><td>0.17</td><td>0.255</td></tr><tr><td>
<italic>SSPO</italic>
</td><td>1005603</td><td>chr7</td><td>149,516,881</td><td>S4028I</td><td>cSNP</td><td>.</td><td>.</td><td>.</td><td>1</td><td>0.2</td><td>0.19</td><td>0.181</td></tr><tr><td>
<italic>TTC40</italic>
</td><td>.</td><td>chr10</td><td>134,679,632</td><td>T1596M</td><td>cSNP</td><td>.</td><td>.</td><td>.</td><td>.</td><td>.</td><td></td><td>.</td></tr><tr><td>Rare variant</td><td colspan="12"></td></tr><tr><td>
<italic>COL6A6</italic>
</td><td>200963433</td><td>chr3</td><td>130,289,976</td><td>R906C</td><td>cSNP</td><td>0</td><td>1</td><td>4.596</td><td>1</td><td>0.0014</td><td>0.01</td><td>0.017</td></tr><tr><td>
<italic>CDX1</italic>
</td><td>370852694</td><td>chr5</td><td>149,546,819</td><td>A127E</td><td>cSNP</td><td>0.87</td><td>0.458</td><td>1.235</td><td>0.996</td><td>.</td><td>.</td><td>0.027</td></tr></tbody></table></table-wrap>
</p>
<p>The genotypes of the 14 genes were further assessed in an exome analysis. Affected fathers and children were heterozygous, while unaffected mothers and children were homozygous wild type for all 14 candidate genes (Table <xref ref-type="table" rid="Tab1">1</xref>).</p>
<p>The chromosome position, amino acid change, and functional prediction score for each of the 14 overlapping genes are presented for each family. The 14 candidate genes were deemed functionally interesting and supported by the SIFT scores (probability of being damaging/deleterious) and the results of the PhyloP analysis (highly conserved among 100 vertebrate species). The significantly low SIFT and high PhyloP and Phastcon scores of <italic>COL6A6</italic> found in all three families signify deleterious protein function. Furthermore, when the Korean filter was applied to <italic>COL6A6</italic>, all three families showed a genetic variant with an MAF range of 1.7–18%, as measured in 800 Koreans subjects (Tables <xref ref-type="table" rid="Tab3">3</xref>, <xref ref-type="table" rid="Tab4">4</xref> and <xref ref-type="table" rid="Tab5">5</xref>).</p>
<p>To reduce errors from WES, <italic>COL6A6</italic> was analyzed by Sanger sequencing to detect SNPs in all three families. The variants we identified were in positions consistent with those of the WES results. In Family A, the missense mutations c.5216G &gt; A, p.Arg1739Glu (common variant), and c.2716C &gt; T, p.Arg906Cys (rare variant) were detected in the affected family members, but not in unaffected family members (Fig. <xref ref-type="fig" rid="Fig1">1a</xref> and <xref ref-type="fig" rid="Fig1">b</xref>). In Family B, the missense mutation c.1666C &gt; T, p.Pro555Ser (common variant) was only found in the affected members (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>). In Family C, the missense mutation c.2716C &gt; T, p.Arg906Cys (rare variant) was also only detected in the affected members (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Single-nucleotide polymorphisms (SNPs) in coding regions of <italic>COL6A6</italic> in three families. The missense mutation was detected by Sanger sequencing analysis in each family (<bold>a</bold>-<bold>d</bold>)</p></caption><graphic id="MO2" xlink:href="12881_2017_368_Fig1_HTML"></graphic></fig>
</p>
<p>Additionally, to investigate the possibility of <italic>COL6A6</italic> variants (rs16830494, rs59021909, and rs200963433) as candidate risk factors for AD, Sanger sequencing was also performed in a case-control study involving 112 patients with AD and 61 control subjects. The allele and genotype frequencies were counted (Table <xref ref-type="table" rid="Tab6">6</xref>). Odds ratios (OR) and 95% confidence intervals (CI) were estimated for all risk factors (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S2). No significant associations were found in these three variants under either dominant or recessive models. However, a minor allele (A) of the common variant rs16830494 showed a tendency toward lower frequency. Homozygosity for the rs16830494 minor allele (AA) and for the rs59021909 (TT) allele were more frequent in AD cases compared to controls. The rs200963433 is a rare variant; the 3.5% heterozygous frequency (CT) of rs200963433 seen in the AD cases was double the 1.6% frequency observed in healthy controls (Table <xref ref-type="table" rid="Tab6">6</xref>). The frequency of rs200963433 in Sanger sequencing was also compared with the frequency of 1000 global, 286 East Asian, and 800 Korean subjects. The 1.7% MAF of rs200963433 in the 800 Koreans surveyed nearly matched that of the 61 health controls in Sanger sequencing, and the MAF was elevated in AD cases (Tables <xref ref-type="table" rid="Tab3">3</xref> and <xref ref-type="table" rid="Tab6">6</xref>).<table-wrap id="Tab6"><label>Table 6</label><caption><p>Allele and genotype frequencies of <italic>COL6A6</italic> polymorphisms in 112 Korean AD patients and 61 controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNP</th><th></th><th></th><th>Controls, n (%)</th><th>AD, n (%)</th></tr></thead><tbody><tr><td>rs16830494</td><td>Allele</td><td>G</td><td>99 (81.1)</td><td>189 (84.4)</td></tr><tr><td>(c.5216G &gt; A)</td><td></td><td>A</td><td>23 (18.9)</td><td>35 (15.6)</td></tr><tr><td></td><td>Genotype</td><td>GG</td><td>39 (63.9)</td><td>79 (71.2)</td></tr><tr><td></td><td></td><td>GA</td><td>21 (34.4)</td><td>29 (26.1)</td></tr><tr><td></td><td></td><td>AA</td><td>1 (1.6)</td><td>3 (2.7)</td></tr><tr><td>rs59021909</td><td>Allele</td><td>C</td><td>108 (88.5)</td><td>199 (88.8)</td></tr><tr><td>(c.1666C &gt; T)</td><td></td><td>T</td><td>14 (11.5)</td><td>25 (11.2)</td></tr><tr><td></td><td>Genotype</td><td>CC</td><td>47 (77.0)</td><td>89 (79.5)</td></tr><tr><td></td><td></td><td>CT</td><td>14 (23.0)</td><td>21 (18.8)</td></tr><tr><td></td><td></td><td>TT</td><td>0 (0)</td><td>2 (1.8)</td></tr><tr><td>rs200963433</td><td>Allele</td><td>C</td><td>121 (99.2)</td><td>220 (98.2)</td></tr><tr><td>(c.2716C &gt; T)</td><td></td><td>T</td><td>1 (0.8)</td><td>4 (1.8)</td></tr><tr><td></td><td>Genotype</td><td>CC</td><td>60 (98.4)</td><td>108 (96.4)</td></tr><tr><td></td><td></td><td>CT</td><td>1 (1.6)</td><td>4 (3.6)</td></tr><tr><td></td><td>.</td><td>TT</td><td>0 (0)</td><td>0 (0)</td></tr></tbody></table></table-wrap>
</p>
<p>We compared the genetic loci between AD candidate variants identified via WES and in AD-linked chromosomal regions. In previous studies, AD-related chromosome loci were detected using AD linkage analysis. The <italic>CDX1</italic>, <italic>ANKRD35</italic>, and <italic>TUFT1</italic> genes were present at positions 5q31-33 and 1q21. <italic>COL6A6</italic> was in close proximity to the 3q21 locus, which is known to be linked to AD (Table <xref ref-type="table" rid="Tab7">7</xref>).<table-wrap id="Tab7"><label>Table 7</label><caption><p>Five candidate genes within AD susceptibility loci identified through genetic linkage analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Chr</th><th>POS</th><th>Locus of AD-linkage</th></tr></thead><tbody><tr><td>
<italic>COL6A6</italic>
</td><td>3</td><td align="char" char=".">130.2–4 Mb<sup>a</sup>
</td><td>3q21 (chr3 122.2 Mb–129.5 Mb) [<xref ref-type="bibr" rid="CR11">11</xref>]</td></tr><tr><td>
<italic>CDX1</italic>
</td><td>5</td><td align="char" char=".">149.5 Mb</td><td>5q31-33 (Chr5 131.2 Mb–160.5 Mb) [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td>
<italic>ANKRD35</italic>
</td><td>1</td><td align="char" char=".">145.5 Mb</td><td>1q21 (Chr1 143.2 Mb–155.1 Mb) [<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td>
<italic>TUFT1</italic>
</td><td>1</td><td align="char" char=".">151.5 Mb</td><td>1q21 (Chr1 143.2 Mb–155.1 Mb)</td></tr><tr><td>
<italic>FLG</italic>
</td><td>1</td><td align="char" char=".">152.2 Mb</td><td>1q21 (Chr1 143.2 Mb–155.1 Mb)</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Mb = mega base pairs = 1,000,000 bp</p></table-wrap-foot></table-wrap>
</p>
<p>We also detected SNPs in filaggrin (<italic>FLG</italic>) and <italic>FLG2</italic> in these three families. <italic>FLG</italic> polymorphisms at the 1q21 locus were observed in three families, respectively (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S3).</p>
</sec>
</sec>
<sec id="Sec10">
<title>Discussion</title>
<p>Early-onset AD is a phenotype that may be associated with a higher risk of multiple allergies and asthma [<xref ref-type="bibr" rid="CR16">16</xref>]. The identification of specific genes predictive of early-onset AD may lead to AD prevention and better management.</p>
<p>To identify familial candidate genes related to early-onset AD, we recruited three families with this phenotype. A family-based design has the advantages of being cost-effective and the ability to discover rare variants not detectable in a population study [<xref ref-type="bibr" rid="CR17">17</xref>]. De novo gene mutations capable of influencing AD susceptibility can also be identified in affected individuals by comparison with unaffected individuals in a family.</p>
<p>Family-specific candidate AD genes were detected using WES. Considerable numbers of common and rare variants were identified in each of the three families. To identify highly critical genes for AD, we confirmed 14 overlapping genes in these families. Variants of the overlapping genes were predicted to be deleterious through functional prediction algorithms. The results of previous AD association studies and the functions of candidate genes were also examined.</p>
<p>Common and rare variants of <italic>COL6A6</italic> were found in all three families. The <italic>COL6A6</italic> gene encodes collagen type VI alpha 6, the α6-chain of an extracellular matrix protein that is widely expressed in human skin and maintains skeletal muscle and skin integrity [<xref ref-type="bibr" rid="CR18">18</xref>]. <italic>COL6A6</italic> is in close proximity to 3q21. In previous studies, AD-associated loci were confirmed by whole-genome linkage scans. The 3q21 locus has been identified as an AD susceptibility region [<xref ref-type="bibr" rid="CR11">11</xref>]. Another genome-wide linkage study found highly significant evidence of a linkage to chromosome 3q21. Moreover, significant evidence has linked this locus with allergic sensitization presumably by paternal imprinting, further supporting the presence of an atopy-related gene in this region [<xref ref-type="bibr" rid="CR19">19</xref>]. <italic>CD80</italic> and <italic>CD86</italic> are major candidate genes located on 3q21 that are expressed by antigen-presenting cells and are essential to T cell activation [<xref ref-type="bibr" rid="CR20">20</xref>]. <italic>COL6A5</italic>, the other collagen alpha-chain, is also linked to AD. A lack of <italic>COL6A5</italic> expression affects epidermal integrity and function [<xref ref-type="bibr" rid="CR21">21</xref>]. Early onset-AD has a prevalence of 15–20% in industrialized countries [<xref ref-type="bibr" rid="CR4">4</xref>]. The MAF (1.7–18%) of <italic>COL6A6</italic> variants in a large sample of the Korean population was similar to the incidence rate of early-onset AD. Our findings suggest that variants of <italic>COL6A6</italic> may be novel candidates for early-onset AD in Koreans.</p>
<p>No significant association with AD was identified among the three <italic>COL6A6</italic> variants per the Odds ratios used in the case-control study. However, a high frequency of homo alt was detected in rs16830494 and rs59021909 in AD cases relative to controls. It was difficult to obtain <italic>p</italic>-values for rare variants using Odds ratio, a common limitation [<xref ref-type="bibr" rid="CR22">22</xref>]. The similar frequencies of rs200963433 in both the 800 Korean population and the 61 healthy controls demonstrate the credibility of the data despite the small study size.</p>
<p>A rare variant of the caudal type homeobox1 (<italic>CDX1</italic>) gene was detected in two families. <italic>CDX1</italic> is located in a candidate AD-linkage region, 5q31-33 [<xref ref-type="bibr" rid="CR23">23</xref>]. The function of the <italic>CDX1</italic> gene is to inhibit β-catenin/T-cell factor transcriptional activity. β-catenin regulates cell-cell adhesion, and Wnt/β-catenin signaling is associated with skin development [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. A common variant of the ultraviolet (UV)-stimulated scaffold protein A (UVSSA) gene was also identified. The function of the <italic>UVSSA</italic> gene is to repair DNA damaged by UV rays. The function of any other genes assumed the association of AD was not found.</p>
<p>Missense mutations of <italic>FLG</italic> and <italic>FLG2</italic> were detected in three families, respectively. The effects of the FLG polymorphism on AD are not well characterized. However, Seon-Young et al. recently reported that the <italic>FLG</italic> (rs11584340) polymorphism is associated with a higher AD risk in the Korean population, and that it affects free fatty acids in serum of AD patients [<xref ref-type="bibr" rid="CR26">26</xref>]. Loss‐of‐function mutations involving <italic>FLG</italic> strongly predispose the carrier to early-onset AD, but not to late-onset AD [<xref ref-type="bibr" rid="CR27">27</xref>]. This study suggests that genetic screening is crucial for identifying risk variants of early-onset AD.</p>
<p>Individually gathered rare variants have severe effects and play important roles in complex human disorders [<xref ref-type="bibr" rid="CR28">28</xref>]. Thus, our data will help to expand genetic studies of AD.</p>
</sec>
<sec id="Sec11">
<title>Conclusions</title>
<p>Identifying family-specific <italic>COL6A6</italic> polymorphisms and genetic variants of other candidate genes associated with AD using WES is a novel approach. Our study suggests that <italic>COL6A6</italic> variants may constitute candidate risk factors for AD development, as identified via family-based WES and a non-familial case-control study of 173 subjects. This study provides a genetic basis for early-onset AD diagnosis in Korean patients and the development of new therapies.</p>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec12">
<title>Additional file</title>
<p>
<media id="MOESM1" position="anchor" xlink:href="12881_2017_368_MOESM1_ESM.pdf"><label>Additional file 1: Table S1.</label><caption><p>Clinical characteristics of the subjects. <bold>Table S2.</bold> Odds ratios (ORs) and 95% confidence intervals (CIs) for atopic dermatitis associated with COL6A6 polymorphisms in Korean patients. <bold>Table S3.</bold> Fliaggrin variants detected in three families. <bold>Figure S1.</bold> Pedigree diagrams of three families with atopic dermatitis. <bold>Figure S2.</bold> Flow chart of the process for filtering variants. <bold>Figure S3.</bold> A Venn diagram showing the number of overlapping genes. (PDF 258 kb)</p></caption></media>
</p>
</sec>
</app>
</app-group>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>AD</term>
<def>
<p>Atopic dermatitis</p>
</def>
</def-item>
<def-item>
<term>CD-CV</term>
<def>
<p>Common disease-common variant</p>
</def>
</def-item>
<def-item>
<term>EDC</term>
<def>
<p>Epidermal differentiation complex</p>
</def>
</def-item>
<def-item>
<term>GWASs</term>
<def>
<p>Genome-wide association studies</p>
</def>
</def-item>
<def-item>
<term>MAF</term>
<def>
<p>Minor allele frequency</p>
</def>
</def-item>
<def-item>
<term>SNPs</term>
<def>
<p>Single-nucleotide polymorphisms</p>
</def>
</def-item>
<def-item>
<term>WES</term>
<def>
<p>Whole-exome sequencing</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>We thank all participants who made this study possible.</p>
<sec id="FPar1">
<title>Funding</title>
<p>This study was supported by a grant from the Korean Healthcare Technology R&amp;D Project, Ministry of Health &amp; Welfare, Republic of Korea (HI14C2687).</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>All data generated during this study are included in this published article and its Additional file <xref ref-type="media" rid="MOESM1">1</xref>.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>WIH, KYP, and SJS conceived and designed the study. TJ, MKL, EHC, and NJM recruited subjects. WIH, TJ, and MKL performed all of the laboratory work. WIH, KYP, and MJK performed all data analysis. EHC, HSK, and JMB performed the statistical analysis. WIH drafted the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar6">
<title>Ethics approval and consent to participate</title>
<p>This study was reviewed and approved by the Chung-Ang University Hospital Institutional Review Board (IRB). The recruitment and consent of participants were conducted on the basis of IRB below.</p>
<p>Trial registration number: IRB NO. C2008030 (133); Name of registry: The collection research of clinical data and patient blood to identify genetic and protein biomarker of atopic dermatitis; Date of registration: 09-July-2008.</p>
<p>Trial registration number: IRB NO. C2015258 (1716); Name of registry: The collection study of patient blood and clinical data for the development of the prognosis prediction and early diagnosis of atopic dermatitis; Date of registration: 15-jan-2016.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<mixed-citation publication-type="other">Hoffjan S, Stemmler S. Unravelling the complex genetic background of atopic dermatitis: from genetic association results towards novel therapeutic strategies. Arch Dermatol Res. 2015;307(8):659–70.</mixed-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uehara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Descendant family history of atopic dermatitis</article-title>
<source/>Acta Derm Venereol
          <year>1993</year>
<volume>73</volume>
<issue>1</issue>
<fpage>62</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">8095756</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kryukov</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Pennacchio</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Most rare missense alleles are deleterious in humans: implications for complex disease and association studies</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>80</volume>
<issue>4</issue>
<fpage>727</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1086/513473</pub-id>
<pub-id pub-id-type="pmid">17357078</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nutten</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Atopic dermatitis: global epidemiology and risk factors</article-title>
<source/>Ann Nutr Metab
          <year>2015</year>
<volume>66</volume>
<issue>Suppl 1</issue>
<fpage>8</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1159/000370220</pub-id>
<pub-id pub-id-type="pmid">25925336</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabbani</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tekin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mahdieh</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The promise of whole-exome sequencing in medical genetics</article-title>
<source/>J Hum Genet
          <year>2014</year>
<volume>59</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2013.114</pub-id>
<pub-id pub-id-type="pmid">24196381</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pabinger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dander</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Snajder</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sperk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Efremova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krabichler</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Speicher</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Trajanoski</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>A survey of tools for variant analysis of next-generation genome sequencing data</article-title>
<source/>Brief Bioinform
          <year>2014</year>
<volume>15</volume>
<issue>2</issue>
<fpage>256</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1093/bib/bbs086</pub-id>
<pub-id pub-id-type="pmid">23341494</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asimit</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zeggini</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Testing for rare variant associations in complex diseases</article-title>
<source/>Genome Med
          <year>2009</year>
<volume>1</volume>
<issue>11</issue>
<fpage>24</fpage>
<pub-id pub-id-type="pmid">21542888</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marigorta</surname>
<given-names>UM</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>High trans-ethnic replicability of GWAS results implies common causal variants</article-title>
<source/>PLoS Genet
          <year>2013</year>
<volume>9</volume>
<issue>6</issue>
<fpage>e1003566</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1003566</pub-id>
<pub-id pub-id-type="pmid">23785302</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Rare and common variants: twenty arguments</article-title>
<source/>Nat Rev Genet
          <year>2011</year>
<volume>13</volume>
<issue>2</issue>
<fpage>135</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3118</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mehla</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Association of a chromosome 1q21 locus in close proximity to a late cornified envelope-like proline-rich 1 (LELP1) gene with total serum IgE levels</article-title>
<source/>J Hum Genet
          <year>2007</year>
<volume>52</volume>
<issue>4</issue>
<fpage>378</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1007/s10038-007-0118-5</pub-id>
<pub-id pub-id-type="pmid">17387579</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christensen</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Moller-Larsen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nyegaard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haagerup</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hedemand</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brasch-Andersen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kruse</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Corydon</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Deleuran</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Borglum</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>Linkage of atopic dermatitis to chromosomes 4q22, 3p24 and 3q21</article-title>
<source/>Hum Genet
          <year>2009</year>
<volume>126</volume>
<issue>4</issue>
<fpage>549</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-009-0692-z</pub-id>
<pub-id pub-id-type="pmid">19517137</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<issue>14</issue>
<fpage>1754</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
<pub-id pub-id-type="pmid">19451168</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poplin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Garimella</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Maguire</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Philippakis</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>del Angel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rivas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>5</issue>
<fpage>491</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
<pub-id pub-id-type="pmid">21478889</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cingolani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Platts</surname>
<given-names>A</given-names>
</name>
<name>
<surname>le Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Land</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ruden</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3</article-title>
<source/>Fly
          <year>2012</year>
<volume>6</volume>
<issue>2</issue>
<fpage>80</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.4161/fly.19695</pub-id>
<pub-id pub-id-type="pmid">22728672</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cibulskis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Sivachenko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sougnez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meyerson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Getz</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</article-title>
<source/>Nat Biotechnol
          <year>2013</year>
<volume>31</volume>
<issue>3</issue>
<fpage>213</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.2514</pub-id>
<pub-id pub-id-type="pmid">23396013</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlsten</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dimich-Ward</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dybuncio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chan-Yeung</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors</article-title>
<source/>Ann Allergy Asthma Immunol
          <year>2013</year>
<volume>110</volume>
<issue>1</issue>
<fpage>24</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.anai.2012.10.005</pub-id>
<pub-id pub-id-type="pmid">23244654</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Population-based and family-based designs to analyze rare variants in complex diseases</article-title>
<source/>Genet Epidemiol
          <year>2011</year>
<volume>35</volume>
<issue>Suppl 1</issue>
<fpage>S41</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1002/gepi.20648</pub-id>
<pub-id pub-id-type="pmid">22128057</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabatelli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gara</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Grumati</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Urciuolo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gualandi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Curci</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Squarzoni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zamparelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martoni</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Merlini</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of the collagen VI alpha5 and alpha6 chains in normal human skin and in skin of patients with collagen VI-related myopathies</article-title>
<source/>J Invest Dermatol
          <year>2011</year>
<volume>131</volume>
<issue>1</issue>
<fpage>99</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2010.284</pub-id>
<pub-id pub-id-type="pmid">20882040</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Wahn</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Kehrt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tarani</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Businco</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Oranje</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Wolkertstorfer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>v Berg</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A major susceptibility locus for atopic dermatitis maps to chromosome 3q21</article-title>
<source/>Nat Genet
          <year>2000</year>
<volume>26</volume>
<issue>4</issue>
<fpage>470</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1038/82625</pub-id>
<pub-id pub-id-type="pmid">11101848</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becker</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>KC</given-names>
</name>
</person-group>
<article-title>Underlying disease specificity of genetic loci in atopic dermatitis</article-title>
<source/>J Invest Dermatol
          <year>2001</year>
<volume>117</volume>
<issue>5</issue>
<fpage>1325</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.01559.x</pub-id>
<pub-id pub-id-type="pmid">11710954</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soderhall</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marenholz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kerscher</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ruschendorf</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Esparza-Gordillo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Worm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mayr</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis</article-title>
<source/>PLoS Biol
          <year>2007</year>
<volume>5</volume>
<issue>9</issue>
<fpage>e242</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.0050242</pub-id>
<pub-id pub-id-type="pmid">17850181</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merner</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Bourassa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Dion</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Kahle</surname>
<given-names>KT</given-names>
</name>
</person-group>
<article-title>Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophrenia</article-title>
<source/>Front Cell Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>386</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00386</pub-id>
<pub-id pub-id-type="pmid">26528127</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmer</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cookson</surname>
<given-names>WO</given-names>
</name>
<name>
<surname>Deichmann</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Elston</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Holloway</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Laitinen</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Meta-analysis for linkage to asthma and atopy in the chromosome 5q31-33 candidate region</article-title>
<source/>Hum Mol Genet
          <year>2001</year>
<volume>10</volume>
<issue>8</issue>
<fpage>891</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/10.8.891</pub-id>
<pub-id pub-id-type="pmid">21523954</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ezaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sinclair</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity</article-title>
<source/>J Biol Chem
          <year>2004</year>
<volume>279</volume>
<issue>35</issue>
<fpage>36865</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M405213200</pub-id>
<pub-id pub-id-type="pmid">15215241</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<mixed-citation publication-type="other">Lim X, Nusse R. Wnt signaling in skin development, homeostasis, and disease. Cold Spring Harb Perspect Biol. 2013;5(2).</mixed-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pyo</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between P478S polymorphism of the filaggrin gene &amp; atopic dermatitis</article-title>
<source/>Indian J Med Res
          <year>2013</year>
<volume>138</volume>
<issue>6</issue>
<fpage>922</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">24521637</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rupnik</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rijavec</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Korošec</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Filaggrin loss‐of‐function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood</article-title>
<source/>Br J Dermatol
          <year>2015</year>
<volume>172</volume>
<issue>2</issue>
<fpage>455</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1111/bjd.13477</pub-id>
<pub-id pub-id-type="pmid">25314673</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McClellan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Genetic heterogeneity in human disease</article-title>
<source/>Cell
          <year>2010</year>
<volume>141</volume>
<issue>2</issue>
<fpage>210</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.03.032</pub-id>
<pub-id pub-id-type="pmid">20403315</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holloway</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Lonjou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Beghe</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Gaunt</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>IP</given-names>
</name>
<name>
<surname>Dewar</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>NS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families</article-title>
<source/>Genes Immun
          <year>2001</year>
<volume>2</volume>
<issue>1</issue>
<fpage>20</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1038/sj.gene.6363723</pub-id>
<pub-id pub-id-type="pmid">11294563</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>